CD36 is a receptor for oxidized high density lipoprotein: implications for the development of atherosclerosis

Area of Science:

• Molecular Biology
• Cardiovascular Research
• Cell Biology

Background:

• Atherosclerotic plaque formation involves excessive cholesterol ester deposition.
• Tissue macrophages in arterial intima play a critical role in atherogenesis.
• Lipoprotein modification, particularly oxidation, is implicated in plaque development.

Purpose of the Study:

• To investigate the role of the macrophage scavenger receptor CD36 in lipid uptake from modified lipoproteins.
• To determine if CD36 mediates lipid uptake from oxidized high-density lipoprotein (oxHDL).
• To compare the uptake mechanisms of oxHDL with other lipoproteins.

Main Methods:

• Utilized a transfection system with two human cell lines.
• Assessed lipid uptake mediated by the macrophage scavenger receptor CD36.
• Compared uptake from native HDL, low-density lipoprotein (LDL), and Cu(2+)-oxidized HDL (oxHDL).

Main Results:

• CD36 selectively mediated lipid uptake from Cu(2+)-oxidized HDL, but not from native HDL or LDL.
• The uptake of oxHDL via CD36 showed similarities to CD36-dependent oxidized LDL uptake.
• Macrophage CD36 binding and internalization of oxHDL were demonstrated.

Conclusions:

• The macrophage scavenger receptor CD36 plays a specific role in the uptake of oxidized HDL.
• CD36-mediated uptake of oxHDL may contribute significantly to the development of atherosclerotic plaques (atheroma).
• Targeting CD36 could be a potential strategy for managing atherosclerosis.